Prognostic value of circulating endothelial cells in metastatic colorectal cancer
Authors:
Open Access
- 21 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37491-37501
Abstract
Prognostic value of circulating endothelial cells in metastatic colorectal cancer Prognostic value of circulating endothelial cells in metastatic colorectal cancerKeywords
This publication has 53 references indexed in Scilit:
- An elevated preoperative serum carbohydrate antigen 19‐9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancerColorectal Disease, 2015
- Effect of standard chemotherapy and antiangiogenic therapy on plasma markers and endothelial cells in colorectal cancerBritish Journal of Cancer, 2014
- Significance of CEA and CA19-9 Combination as a Prognostic Indicator and for Recurrence Monitoring in Patients with Stage II Colorectal Cancer2014
- Prognostic relevance of minimal residual disease in colorectal cancerWorld Journal of Gastroenterology, 2014
- Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patientsEuropean Journal of Cancer, 2011
- Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancerCancer Chemotherapy and Pharmacology, 2010
- Circulating endothelial cells, bone marrow-derived endothelial progenitor cells and proangiogenic hematopoietic cells in cancer: From biology to therapyCritical Reviews in Oncology/Hematology, 2009
- Relationship of Circulating Tumor Cells to Tumor Response, Progression-Free Survival, and Overall Survival in Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2008
- Tumor markers in staging and prognosis of colorectal carcinoma.2008
- Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapyNature Medicine, 2001